| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.3 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.4 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.4 |